A vaccination update for rheumatologists-SARS-CoV-2, influenza and herpes zoster

Int J Rheum Dis. 2021 Aug;24(8):979-983. doi: 10.1111/1756-185X.14179.
No abstract available

Publication types

  • Editorial
  • Review

MeSH terms

  • Antirheumatic Agents / adverse effects
  • Antirheumatic Agents / therapeutic use*
  • COVID-19 Vaccines / administration & dosage*
  • COVID-19 Vaccines / adverse effects
  • Herpes Zoster Vaccine / administration & dosage*
  • Herpes Zoster Vaccine / adverse effects
  • Humans
  • Immunocompromised Host
  • Immunogenicity, Vaccine
  • Influenza Vaccines / administration & dosage*
  • Influenza Vaccines / adverse effects
  • Patient Safety
  • Rheumatic Diseases / diagnosis
  • Rheumatic Diseases / drug therapy*
  • Rheumatic Diseases / immunology
  • Rheumatic Diseases / mortality
  • Rheumatologists
  • Rheumatology
  • Risk Assessment
  • Risk Factors
  • Vaccination* / adverse effects
  • Virus Diseases / immunology
  • Virus Diseases / mortality
  • Virus Diseases / prevention & control*
  • Virus Diseases / virology

Substances

  • Antirheumatic Agents
  • COVID-19 Vaccines
  • Herpes Zoster Vaccine
  • Influenza Vaccines